Abstract:Two precision‐targeted nanoparticles PD‐L1@Cur‐NPs and PD‐1@AS‐NPs are constructed for cancer treatment. PD‐L1@Cur‐NPs can precisely target tumor cells to eradicate tumor cells or induce them apoptosis. PD‐1@AS‐NPs can precisely target T cells to activate the T cell‐mediated immune system and induce antitumor immune responses. These two nanoparticles have good synergistic effect and show stronger antitumor effect after combination. Cancer has emerged as a significant threat that gravely endanger human health. Anti‐tumor immunotherapy has now emerged as an important treatment for cancer. However, immunosuppressive tumor microenvironment limits the antitumor immunity. The importance of the immune system in the cancer treatment process must be emphasized. Herein, two precision‐targeted nanoparticles PD‐L1@Cur‐NPs and PD‐1@AS‐NPs are constructed for cancer treatment. PD‐L1@Cur‐NPs can precisely target tumor cells in vivo to eradicate tumor cells or induce them apoptosis. PD‐1@AS‐NPs can precisely target T cells in vivo to activate the T cell‐mediated immune system and induce antitumor immune responses. Furthermore, these two nanoparticles have good synergistic effect and show stronger antitumor effect after combination. After treatment with the combination of two nanoparticles, the tumor volumes of C57BL/6 tumor‐bearing mice are significantly reduced. Moreover, the percentage of CD8+T cells and CD4+T cells in the tumor significantly increased, and the percentage of regulatory T cells significantly decreased. The percentage of memory T cells and memory effector T cells in the spleen also significantly increased after treatment, suggesting that the antitumor immunity is activated after treatment. This study provides a new antitumor treatment strategy combining chemotherapy and immunotherapy, which has good application prospect.

Diselenide–Pemetrexed Assemblies for Combined Cancer Immuno‐, Radio‐, and Chemotherapies

A Powerful Antitumor “trident”: the Combination of Radio-, Immuno- and Anti-Angiogenesis Therapy Based on Mesoporous Silica Single Coated Gold Nanoparticles

Selenium-containing Nanoparticles Synergistically Enhance Pemetrexed&NK Cell-Based Chemoimmunotherapy.

Pemetrexed–Poly(salicylic Acid) Assemblies Reshape Immunosuppressive Tumor Microenvironment for Enhanced Chemo-immunotherapy

Selenium-Containing Carrier-Free Assemblies with Aggregation-Induced Emission Property Combine Cancer Radiotherapy with Chemotherapy

Selenium‐Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy

Diselenium-containing ultrathin polymer nanocapsules for highly efficient targeted drug delivery and combined anticancer effect

Low-Dose X-ray-Responsive Diselenide Nanocarriers for Effective Delivery of Anticancer Agents

Radiation-Sensitive Diselenide Block Co-Polymer Micellar Aggregates: Toward the Combination of Radiotherapy and Chemotherapy

Self-Assembled Metal-Phenolic Network Nanoparticles Delivery of Cisplatin Prodrug for Synergistic Chemo-Immunotherapy

From Selenite To Diselenide-Containing Drug Delivery Systems

Chemoimmunotherapy: Coordination and Redox Dual‐Responsive Mesoporous Organosilica Nanoparticles Amplify Immunogenic Cell Death for Cancer Chemoimmunotherapy (Small 26/2021)

Selenopeptide Nanomedicine Activates Natural Killer Cells for Enhanced Tumor Chemoimmunotherapy

CO/chemosensitization/antiangiogenesis synergistic therapy with H2O2-responsive diselenide-containing polymer.

Elaborately Engineering of a Dual-Drug Co-Assembled Nanomedicine for Boosting Immunogenic Cell Death and Enhancing Triple Negative Breast Cancer Treatment

Breaking the Intracellular Redox Balance with Diselenium Nanoparticles for Maximizing Chemotherapy Efficacy on Patient-Derived Xenograft Models

Combination Nanodrug Delivery Systems Facilitate the Syncretism of Chemotherapy with Immunotherapy to Promote Cancer Treatment

Selenium‐Containing Nanocomplexes Achieve Dual Immune Checkpoint Blockade for NK Cell Reinvigoration

A Drug‐Free Therapeutic System for Cancer Therapy by Diselenide‐Based Polymers Themselves

Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics

Engineering Diselenide-IR780 Homodimeric Nanoassemblies with Enhanced Photodynamic and Immunotherapeutic Effects for Triple-Negative Breast Cancer Treatment